Location: Home
  • search
  • go
  • Relate News
  • 1/21/2021Lesson from China's National Negotiation of Drug Prices in 2020
  • 1/19/2021Innovent Announces an Out-license Deal with PT Etana to Launch Bevaciz...
  • 1/19/2021NMPA Revises Packages Inserts of Pamidronate Disodium Injection
  • 1/19/2021TRACON Granted Priority Review Acceptance of Envafolimab NDA in Chin...
  • 1/18/2021Kyowa Kirin Granted Conditional Approval of Crysvita (burosumab) in Ch...
  • 1/18/2021Top JPMorgan Banker Sees Steady Supply of Chinese Health Care IPOs, Ev...
  • 1/15/2021CDE Issues the Technical Guidelines for Quality Studies of TCM New Dru...
  • 1/15/2021Innovent's sNDA for Sintilimab as Second-line Therapy for Squamous NSC...
  • 1/15/2021JPO Issues Bidding Documents for the Fourth Batch of VBP
  • 1/15/2021Recent Executive Moves
  • 1/14/2021NHSA Highlights Ten Major Tasks in 2021
  • 1/14/2021Chiome and Henlius Sign Greater China Licensing Deal for Anti-TPOR-2 A...
  • 1/14/2021What Do Novartis Deal, PD-1 Competition In China Mean For Tislelizumab...
  • 1/14/2021Pharma Companies to Cut Prices of News Drugs by 51% to Access Chinese ...
  • 1/13/2021Domestic PD-1s in the 2020 NRDL Negotiated Entry: Winners Take All
  • 1/13/2021Sesen Bio and Qilu Pharma Announce Acceptance IND for Vicineum  in C...
  • 1/13/2021BeiGene Granted Chinese Approval of Tislelizumab in Combo with Chemoth...
  • 1/12/2021Swiss Re Sees Short-term Health insurance as Growth Driver in China
  • 1/11/2021Chi-Med and Inmagene Announce Partnership for Portfolio of Drug Candi...
  • 1/11/2021Strand Therapeutics and BeiGene Enter into Agreement to Develop Solid ...
  • 1/11/2021NHSA Issues Two Interim Rules for Management of BMI Designated Medical...
  • 1/8/2021Everest Medicines Announces CTA Approval for P3 Trial of Sacituzumab G...
  • 1/8/2021Recent Executive Moves
  • 1/8/2021SMCP - Coronavirus in China: 2021 Outlook Brightens for Health Care Op...
  • 1/8/2021S&P Global: China's Big Tech to Continue Disruption of Healthcare Sect...
  • 1/7/2021Apollomics Granted Breakthrough Therapy Designation for AML Drug APL-1...
  • 1/6/2021NHC Issues Two New Documents on Public Hospital Management
  • 1/6/2021Eli Lilly Granted Chinese Approval of Verzenio (Abemaciclib)
  • 1/6/2021Immedica and Winhealth Sign Deal for UCD Drug Ravicti in Greater Chin...
  • 1/6/2021Argenx and Zai Lab Enter Strategic Deal for Efgartigimod in Greater Ch...
  • Page:109/367 Total number of articles:10986: [First][<<] [107] [108] [109] [110] [111] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group